Avita Medical Inc. amended its Credit Agreement with OrbiMed Advisors, adjusting revenue covenants for upcoming quarters and issuing warrants for 145,180 shares at $0.01 each. The company also announced its financial results for the fourth quarter and full year 2024, with specific revenue targets set for the next quarters.